1. Home
  2. HTLD vs IMTX Comparison

HTLD vs IMTX Comparison

Compare HTLD & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heartland Express Inc.

HTLD

Heartland Express Inc.

SELL

Current Price

$10.15

Market Cap

860.7M

Sector

Industrials

ML Signal

SELL

Logo Immatics N.V.

IMTX

Immatics N.V.

SELL

Current Price

$6.13

Market Cap

992.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
HTLD
IMTX
Founded
1978
N/A
Country
United States
Germany
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
860.7M
992.8M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
HTLD
IMTX
Price
$10.15
$6.13
Analyst Decision
Hold
Strong Buy
Analyst Count
6
9
Target Price
$11.80
★ $15.97
AVG Volume (30 Days)
567.1K
★ 1.0M
Earning Date
10-20-2026
11-10-2026
Dividend Yield
★ 0.76%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.09
N/A
Revenue
★ $805,709,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.10
$14.22
P/E Ratio
$116.56
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$7.00
$6.07
52 Week High
$16.64
$12.41

Technical Indicators

Market Signals
Indicator
HTLD
IMTX
Relative Strength Index (RSI) 40.51 32.47
Support Level $9.94 N/A
Resistance Level $11.43 $7.95
Average True Range (ATR) 0.42 0.46
MACD 0.05 -0.02
Stochastic Oscillator 14.70 4.10

Price Performance

Historical Comparison
HTLD
IMTX

About HTLD Heartland Express Inc.

Heartland Express Inc, along with its subsidiaries, operates as a short, medium, and long-haul truckload carrier and transportation services provider. It mainly provides nationwide asset-based dry van truckload service for shippers across the United States, along with cross-border freight and other transportation services offered through third-party partnerships in Mexico. The group operates under the brand names of Heartland Express, Millis Transfer, Smith Transport, and CFI (for services within Mexico).

About IMTX Immatics N.V.

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Share on Social Networks: